These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 33261900

  • 1. Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent.
    Szczepańska K, Pockes S, Podlewska S, Höring C, Mika K, Latacz G, Bednarski M, Siwek A, Karcz T, Nagl M, Bresinsky M, Mönnich D, Seibel U, Kuder KJ, Kotańska M, Stark H, Elz S, Kieć-Kononowicz K.
    Eur J Med Chem; 2021 Mar 05; 213():113041. PubMed ID: 33261900
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties.
    Szczepańska K, Podlewska S, Dichiara M, Gentile D, Patamia V, Rosier N, Mönnich D, Ruiz Cantero MC, Karcz T, Łażewska D, Siwek A, Pockes S, Cobos EJ, Marrazzo A, Stark H, Rescifina A, Bojarski AJ, Amata E, Kieć-Kononowicz K.
    ACS Chem Neurosci; 2022 Jan 05; 13(1):1-15. PubMed ID: 34908391
    [Abstract] [Full Text] [Related]

  • 5. Structural modifications and in vitro pharmacological evaluation of 4-pyridyl-piperazine derivatives as an active and selective histamine H3 receptor ligands.
    Szczepańska K, Karcz T, Siwek A, Kuder KJ, Latacz G, Bednarski M, Szafarz M, Hagenow S, Lubelska A, Olejarz-Maciej A, Sobolewski M, Mika K, Kotańska M, Stark H, Kieć-Kononowicz K.
    Bioorg Chem; 2019 Oct 05; 91():103071. PubMed ID: 31362197
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands.
    Kuder KJ, Łażewska D, Kaleta M, Latacz G, Kottke T, Olejarz A, Karcz T, Fruziński A, Szczepańska K, Karolak-Wojciechowska J, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2017 May 15; 25(10):2701-2712. PubMed ID: 28372935
    [Abstract] [Full Text] [Related]

  • 7. New lead elements for histamine H3 receptor ligands in the pyrrolo[2,3-d]pyrimidine class.
    Espinosa-Bustos C, Frank A, Arancibia-Opazo S, Salas CO, Fierro A, Stark H.
    Bioorg Med Chem Lett; 2018 Sep 15; 28(17):2890-2893. PubMed ID: 30025902
    [Abstract] [Full Text] [Related]

  • 8. Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands.
    Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B.
    Eur J Med Chem; 2020 Jan 01; 185():111785. PubMed ID: 31669851
    [Abstract] [Full Text] [Related]

  • 9. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
    Guryn R, Staszewski M, Kopczacki P, Walczyski K.
    Med Chem; 2016 Jan 01; 13(1):65-76. PubMed ID: 27220560
    [Abstract] [Full Text] [Related]

  • 10. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B, Schwed JS, Subramanian D, Weizel L, Walter M, Adem A, Stark H.
    Eur J Med Chem; 2014 Apr 22; 77():269-79. PubMed ID: 24650714
    [Abstract] [Full Text] [Related]

  • 11. Novel naphthyloxy derivatives - Potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation.
    Łażewska D, Kaleta M, Hagenow S, Mogilski S, Latacz G, Karcz T, Lubelska A, Honkisz E, Handzlik J, Reiner D, Satała G, Filipek B, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2018 May 15; 26(9):2573-2585. PubMed ID: 29681486
    [Abstract] [Full Text] [Related]

  • 12. Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation.
    Falkenstein M, Reiner-Link D, Zivkovic A, Gering I, Willbold D, Stark H.
    Bioorg Med Chem; 2021 Nov 15; 50():116462. PubMed ID: 34695709
    [Abstract] [Full Text] [Related]

  • 13. Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties.
    Kuder KJ, Kotańska M, Szczepańska K, Mika K, Reiner-Link D, Stark H, Kieć-Kononowicz K.
    Molecules; 2021 Apr 15; 26(8):. PubMed ID: 33921144
    [Abstract] [Full Text] [Related]

  • 14. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
    Kuder KJ, Stachnik M, Schunack W, Szymańska E, Kieć-Kononowicz K.
    Med Chem; 2014 Apr 15; 10(6):588-99. PubMed ID: 24047214
    [Abstract] [Full Text] [Related]

  • 15. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA.
    J Pharmacol Exp Ther; 2003 Jun 15; 305(3):887-96. PubMed ID: 12606603
    [Abstract] [Full Text] [Related]

  • 16. A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H3 Receptor.
    Rosier N, Grätz L, Schihada H, Möller J, Işbilir A, Humphrys LJ, Nagl M, Seibel U, Lohse MJ, Pockes S.
    J Med Chem; 2021 Aug 12; 64(15):11695-11708. PubMed ID: 34309390
    [Abstract] [Full Text] [Related]

  • 17. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
    Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE.
    Brain Res; 2005 May 31; 1045(1-2):142-9. PubMed ID: 15910772
    [Abstract] [Full Text] [Related]

  • 18. Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol.
    Sadek B, Shehab S, Więcek M, Subramanian D, Shafiullah M, Kieć-Kononowicz K, Adem A.
    Bioorg Med Chem Lett; 2013 Sep 01; 23(17):4886-91. PubMed ID: 23891186
    [Abstract] [Full Text] [Related]

  • 19. Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats.
    Sadek B, Saad A, Latacz G, Kuder K, Olejarz A, Karcz T, Stark H, Kieć-Kononowicz K.
    Drug Des Devel Ther; 2016 Sep 01; 10():3879-3898. PubMed ID: 27932863
    [Abstract] [Full Text] [Related]

  • 20. N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H3 receptor and cancer resistance proteins.
    Szczepańska K, Kincses A, Vincze K, Szymańska E, Latacz G, Kuder KJ, Stark H, Spengler G, Handzlik J, Kieć-Kononowicz K.
    Bioorg Med Chem Lett; 2020 Nov 15; 30(22):127522. PubMed ID: 32871268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.